Thompson Davis & Co., Inc. Geo Vax Labs, Inc. Transaction History

Thompson Davis & Co., Inc.

  • $132 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
BUY
$9.29 - $34.8 $92,899 - $348,000
10,000 New
10,000 $8,000

About GeoVax Labs, Inc.

GOVX Quotes by TradingView
  • Ticker GOVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,744,000
  • Market Cap $55.9M
  • Description
  • GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...
More about GOVX
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email